|
- 2018
Clinical potential of canagliflozin in cardiovascular risk reduction in patients with type 2 diabetesDOI: 10.2147/VHRM.S168472 Keywords: antihyperglycemic, sodium-glucose co-transporter 2 inhibitors, cardiovascular disease, diabetes mellitus Abstract:
|